Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Tumor Resection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06153394
What this trial is testing

Prolonged Hypercoagulability Following Major Liver Resection for Malignancy

Who this might be right for
Hepatic DiseaseSurgery-ComplicationsHypercoagulability+1 more
Western University, Canada 50
Not applicableActive Not RecruitingNCT03651154
What this trial is testing

Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections

Who this might be right for
Liver NeoplasmsHepatectomyBlood Transfusion+1 more
Ottawa Hospital Research Institute 440
Not applicableUnknownNCT01677728
What this trial is testing

Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver Tumor
Xu jianmin 60
Not applicableStudy completedNCT04053998
What this trial is testing

Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org

Who this might be right for
Pancreatic NeoplasmsPancreaticoduodenectomy
Royal Free Hospital NHS Foundation Trust 1,462
Testing effectiveness (Phase 2)Active Not RecruitingNCT06193733
What this trial is testing

Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Chang Gung Memorial Hospital 74
Not applicableUnknownNCT02537158
What this trial is testing

Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Chinese Academy of Medical Sciences 90
Early research (Phase 1)Study completedNCT00264446
What this trial is testing

ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableNot Yet RecruitingNCT07556835
What this trial is testing

Outcomes After Liver and Biliary Resection at a High-Volume Center

Who this might be right for
Liver NeoplasmsHepatobiliary DiseasesCholangiocarcinoma+6 more
Azienda USL Toscana Centro 1,000
Testing effectiveness (Phase 2)UnknownNCT05161143
What this trial is testing

Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Not applicableStudy completedNCT05616039
What this trial is testing

I-FIGS Feasibility Study

Who this might be right for
Liver CancerHepatocellular CarcinomaLiver Metastasis Colon Cancer
University Hospital Plymouth NHS Trust 42
Testing effectiveness (Phase 2)UnknownNCT05407519
What this trial is testing

Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Who this might be right for
Hepatocellular Carcinoma
Anhui Provincial Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00234182
What this trial is testing

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 84
Not applicableActive Not RecruitingNCT06699524
What this trial is testing

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

Who this might be right for
Hepatocellular Carcinoma
Shen Feng 122
Large-scale testing (Phase 3)WithdrawnNCT04546802
What this trial is testing

HepATocellular Cancer Hcv Therapy Study

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cell Carcinoma+1 more
Bayside Health
Not applicableUnknownNCT03904667
What this trial is testing

Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

Who this might be right for
Liver Resection
Zhujiang Hospital 150
Not applicableUnknownNCT01860222
What this trial is testing

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma With CSPH
Eastern Hepatobiliary Surgery Hospital 160
Testing effectiveness (Phase 2)UnknownNCT00077389
What this trial is testing

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

Who this might be right for
Liver Cancer
University of Leicester 57
Testing effectiveness (Phase 2)UnknownNCT03839550
What this trial is testing

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT07658105
What this trial is testing

Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Next Page